Status:
UNKNOWN
Stanford Kids CAMP Study
Lead Sponsor:
Stanford University
Conditions:
Pre-diabetes
Obesity
Eligibility:
All Genders
5-13 years
Phase:
NA
Brief Summary
The Stanford Kids CAMP study aims to evaluate the feasibility of enrolling minority participants in school age children (5-13 years old) in a community summer camp setting along with the efficiency by...
Detailed Description
The proposed study is an outpatient prospective, open-label clinical trial comparing 2 groups: Group 1 (aka BAWSI Camp): the Dexcom G6 Pro Continuous Glucose Monitor and the accelerometer and mobile c...
Eligibility Criteria
Inclusion
- 5-13 years of age.
- Avoidance of acetaminophen-containing medications (i.e. Tylenol) while wearing the continuous glucose monitor.
- Willingness to wear a continuous glucose sensor and physiological monitor for the duration of the study.
- A parent/caregiver is available for system training and will commit to be the main responsible person for the use of the monitoring system at home.
Exclusion
- Have a condition limiting their participation in the interventions (e.g., unable to participate in routine physical education classes at school, requiring oxygen supplementation for exertion, developmental or physical disability preventing participation in interventions, children or parents/guardians who cannot medically participate in mild dietary restrictions and/or increased physical activity for any reason).
- Have a condition limiting participation in the assessments (child or primary caregiver not able to read surveys in English or Spanish, child two or more grade levels delayed in school for reading and writing in her native language).
- Are unable to read, understand or complete informed consent in English or Spanish.
- Are deemed to have another characteristic that makes them unsuitable for participation in the study in the judgment of the Principal Investigators.
Key Trial Info
Start Date :
July 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05380817
Start Date
July 1 2022
End Date
December 31 2022
Last Update
May 19 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University
Stanford, California, United States, 94305